FibroBiologics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2023 | $-2.0M | $-2.1M | $56.0K | $448.0K |
| Jun 2023 | $-1.6M | $-1.6M | $24.0K | $448.0K |
| Sep 2023 | $-1.1M | $-1.6M | $413.0K | $437.0K |
| Dec 2023 | $-1.6M | $-1.6M | $2.0K | $432.0K |
| Mar 2024 | $-4.3M | $-4.3M | $8.0K | $525.0K |
| Jun 2024 | $-1.9M | $-2.0M | $66.0K | $578.0K |
| Sep 2024 | $-2.6M | $-2.6M | $11.0K | $572.0K |
| Dec 2024 | $-3.1M | $-3.2M | $99.0K | $544.0K |
| Mar 2025 | $-5.3M | $-5.3M | $43.0K | $551.0K |
| Jun 2025 | $-4.0M | $-4.2M | $213.0K | $729.0K |
| Sep 2025 | $-4.0M | $-4.0M | $6.0K | $704.0K |
| Dec 2025 | $-3.2M | $-3.2M | $0 | $702.0K |
| Mar 2026 | $-4.4M | $-4.4M | $0 | $694.0K |
| Jun 2026 | $-3.3M | $-3.3M | $0 | $707.0K |